Advertisement
Screener

DAVITA INC. (DVA) Payments to Acquire Equity Method Investments

2.8 / 5 stars · 68/120 Roast Me

DAVITA INC. Payments to Acquire Equity Method Investments

DAVITA INC. (DVA) reported Payments to Acquire Equity Method Investments of $19.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2026-08-04

  • DAVITA INC. payments to acquire equity method investments for the quarter ending 2026-06-30 was $17.32M, a 707.70% increase year-over-year.
  • DAVITA INC. payments to acquire equity method investments for the quarter ending 2026-03-31 was $2.31M.
  • DAVITA INC. payments to acquire equity method investments for the quarter ending 2025-12-31 was $24.56M, a 3369.49% increase year-over-year.
  • DAVITA INC. payments to acquire equity method investments for the quarter ending 2025-09-30 was $322.00K, a 91.52% decline year-over-year.
  • DAVITA INC. payments to acquire equity method investments for fiscal 2025 was $27.03M, a 419.31% increase from fiscal 2024.
  • DAVITA INC. payments to acquire equity method investments for fiscal 2024 was $5.21M, a 98.12% decline from fiscal 2023.
  • DAVITA INC. payments to acquire equity method investments for fiscal 2023 was $276.20M, a 766.24% increase from fiscal 2022.
  • DAVITA INC. payments to acquire equity method investments for fiscal 2022 was $31.89M, a 128.99% increase from fiscal 2021.
Period endPayments to Acquire Equity Method Investments 3 monthPayments to Acquire Equity Method Investments 6 monthPayments to Acquire Equity Method Investments 9 monthPayments to Acquire Equity Method Investments 12 month
2026-06-30$17.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$19.63M
10-Q · filed 2026-08-04
$44.19M
derived: sum of 3 quarters · filed 2026-08-04
$44.51M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$2.31M
10-Q · filed 2026-05-05
$26.87M
derived: sum of 2 quarters · filed 2026-05-05
$27.19M
derived: sum of 3 quarters · filed 2026-05-05
$29.34M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$24.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$24.89M
derived: sum of 2 quarters · filed 2026-02-11
$27.03M
derived: sum of 3 quarters · filed 2026-08-04
$27.03M
10-K · filed 2026-02-11
2025-09-30$322.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$2.47M
derived: sum of 2 quarters · filed 2026-08-04
$2.47M
10-Q · filed 2025-10-29
$3.17M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$2.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$2.14M
10-Q · filed 2026-08-04
$2.85M
derived: sum of 3 quarters · filed 2026-08-04
$6.65M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$0.00
10-Q · filed 2026-05-05
$708.00K
derived: sum of 2 quarters · filed 2026-05-05
$4.50M
derived: sum of 3 quarters · filed 2026-05-05
$4.75M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$708.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$4.50M
derived: sum of 2 quarters · filed 2026-02-11
$4.75M
derived: sum of 3 quarters · filed 2026-02-11
$5.21M
10-K · filed 2026-02-11
2024-09-30$3.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$4.04M
derived: sum of 2 quarters · filed 2025-10-29
$4.50M
10-Q · filed 2025-10-29
$4.69M
derived: sum of 4 quarters · filed 2026-02-11
2024-06-30$240.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$700.00K
10-Q · filed 2025-08-05
$896.00K
derived: sum of 3 quarters · filed 2026-02-11
$3.57M
derived: sum of 4 quarters · filed 2026-02-11
2024-03-31$460.00K
10-Q · filed 2025-05-12
$656.00K
derived: sum of 2 quarters · filed 2026-02-11
$3.33M
derived: sum of 3 quarters · filed 2026-02-11
$268.76M
derived: sum of 4 quarters · filed 2026-02-11
2023-12-31$196.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$2.87M
derived: sum of 2 quarters · filed 2026-02-11
$268.30M
derived: sum of 3 quarters · filed 2026-02-11
$276.20M
10-K · filed 2026-02-11
2023-09-30$2.67M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
$268.10M
derived: sum of 2 quarters · filed 2024-10-29
$276.01M
10-Q · filed 2024-10-29
$279.71M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$265.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$273.34M
10-Q · filed 2024-08-06
$277.05M
derived: sum of 3 quarters · filed 2025-02-13
$281.42M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31$7.90M
10-Q · filed 2024-05-02
$11.61M
derived: sum of 2 quarters · filed 2025-02-13
$15.98M
derived: sum of 3 quarters · filed 2025-02-13
$36.83M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31$3.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$8.08M
derived: sum of 2 quarters · filed 2025-02-13
$28.92M
derived: sum of 3 quarters · filed 2025-02-13
$31.89M
10-K · filed 2025-02-13
2022-09-30$4.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$25.21M
derived: sum of 2 quarters · filed 2023-11-07
$28.18M
10-Q · filed 2023-11-07
$34.17M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30$20.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$23.81M
10-Q · filed 2023-08-03
$29.80M
derived: sum of 3 quarters · filed 2024-02-14
$31.70M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31$2.96M
10-Q · filed 2023-05-08
$8.96M
derived: sum of 2 quarters · filed 2024-02-14
$10.86M
derived: sum of 3 quarters · filed 2024-02-14
$13.69M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$7.89M
derived: sum of 2 quarters · filed 2024-02-14
$10.72M
derived: sum of 3 quarters · filed 2024-02-14
$13.92M
10-K · filed 2024-02-14
2021-09-30$1.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-31
$4.72M
derived: sum of 2 quarters · filed 2022-10-31
$7.92M
10-Q · filed 2022-10-31
$20.65M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$2.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01
$6.03M
10-Q · filed 2022-08-01
$18.76M
derived: sum of 3 quarters · filed 2023-02-22
$20.27M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$3.20M
10-Q · filed 2022-05-05
$15.93M
derived: sum of 2 quarters · filed 2023-02-22
$17.44M
derived: sum of 3 quarters · filed 2023-02-22
$19.37M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$12.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$14.24M
derived: sum of 2 quarters · filed 2023-02-22
$16.17M
derived: sum of 3 quarters · filed 2023-02-22
$22.34M
10-K · filed 2023-02-22
2020-09-30$1.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
$3.44M
derived: sum of 2 quarters · filed 2021-10-28
$9.61M
10-Q · filed 2021-10-28
$10.21M
derived: sum of 4 quarters · filed 2022-02-11
2020-06-30$1.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
$8.10M
10-Q · filed 2021-08-03
$8.70M
derived: sum of 3 quarters · filed 2022-02-11
$10.75M
derived: sum of 4 quarters · filed 2022-02-11
2020-03-31$6.17M
10-Q · filed 2021-04-29
$6.77M
derived: sum of 2 quarters · filed 2022-02-11
$8.82M
derived: sum of 3 quarters · filed 2022-02-11
$11.47M
derived: sum of 4 quarters · filed 2022-02-11
2019-12-31$596.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11
$2.65M
derived: sum of 2 quarters · filed 2022-02-11
$5.30M
derived: sum of 3 quarters · filed 2022-02-11
$9.37M
10-K · filed 2022-02-11
2019-09-30$2.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$4.70M
derived: sum of 2 quarters · filed 2020-10-29
$8.77M
10-Q · filed 2020-10-29
$15.07M
derived: sum of 4 quarters · filed 2021-02-12
2019-06-30$2.65M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$6.71M
10-Q · filed 2020-07-30
$13.02M
derived: sum of 3 quarters · filed 2021-02-12
$15.65M
derived: sum of 4 quarters · filed 2021-02-12
2019-03-31$4.07M
10-Q · filed 2020-05-05
$10.37M
derived: sum of 2 quarters · filed 2021-02-12
$13.00M
derived: sum of 3 quarters · filed 2021-02-12
$20.77M
derived: sum of 4 quarters · filed 2021-02-12
2018-12-31$6.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12
$8.94M
derived: sum of 2 quarters · filed 2021-02-12
$16.70M
derived: sum of 3 quarters · filed 2021-02-12
$19.18M
10-K · filed 2021-02-12
2018-09-30$2.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$10.40M
derived: sum of 2 quarters · filed 2019-11-07
$12.87M
10-Q · filed 2019-11-07
$14.68M
derived: sum of 4 quarters · filed 2020-02-21
2018-06-30$7.76M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
$10.24M
10-Q · filed 2019-08-02
$12.04M
derived: sum of 3 quarters · filed 2020-02-21
$13.86M
derived: sum of 4 quarters · filed 2020-02-21
2018-03-31$2.48M
10-Q · filed 2019-05-07
$4.28M
derived: sum of 2 quarters · filed 2020-02-21
$6.10M
derived: sum of 3 quarters · filed 2020-02-21
$6.16M
derived: sum of 4 quarters · filed 2020-02-21
2017-12-31$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21
$3.62M
derived: sum of 2 quarters · filed 2020-02-21
$3.68M
derived: sum of 3 quarters · filed 2020-02-21
$4.82M
10-K · filed 2020-02-21
2017-09-30$1.82M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$1.88M
derived: sum of 2 quarters · filed 2018-11-07
$3.01M
10-Q · filed 2018-11-07
$18.48M
derived: sum of 4 quarters · filed 2019-02-22
2017-06-30$59.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
$1.19M
10-Q · filed 2018-08-01
$16.66M
derived: sum of 3 quarters · filed 2019-02-22
$19.50M
derived: sum of 4 quarters · filed 2019-02-22
2017-03-31$1.14M
10-Q · filed 2018-05-03
$16.60M
derived: sum of 2 quarters · filed 2019-02-22
$19.45M
derived: sum of 3 quarters · filed 2019-02-22
$22.38M
derived: sum of 4 quarters · filed 2019-02-22
2016-12-31$15.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$18.31M
derived: sum of 2 quarters · filed 2019-02-22
$21.25M
derived: sum of 3 quarters · filed 2019-02-22
$27.10M
10-K · filed 2019-02-22
2016-09-30$2.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$5.78M
derived: sum of 2 quarters · filed 2017-11-07
$11.63M
10-Q · filed 2017-11-07
$15.92M
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$2.94M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01
$8.79M
10-Q · filed 2017-08-01
$13.07M
derived: sum of 3 quarters · filed 2018-02-23
$19.15M
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31$5.85M
10-Q · filed 2017-05-02
$10.14M
derived: sum of 2 quarters · filed 2018-02-23
$16.21M
derived: sum of 3 quarters · filed 2018-02-23
$16.34M
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31$4.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$10.36M
derived: sum of 2 quarters · filed 2018-02-23
$10.48M
derived: sum of 3 quarters · filed 2018-02-23
$17.91M
10-K · filed 2018-02-23
2015-09-30$6.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$6.20M
derived: sum of 2 quarters · filed 2016-11-02
$13.62M
10-Q · filed 2016-11-02
$16.52M
derived: sum of 4 quarters · filed 2017-02-24
2015-06-30$124.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$7.55M
10-Q · filed 2016-08-08
$10.45M
derived: sum of 3 quarters · filed 2017-02-24
$38.18M
derived: sum of 4 quarters · filed 2017-02-24
2015-03-31$7.43M
10-Q · filed 2016-05-04
$10.32M
derived: sum of 2 quarters · filed 2017-02-24
$38.06M
derived: sum of 3 quarters · filed 2017-02-24
2014-12-31$2.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$30.63M
derived: sum of 2 quarters · filed 2017-02-24
$35.38M
10-K · filed 2017-02-24
2014-09-30$27.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$32.48M
10-Q · filed 2015-11-05
2014-06-30$4.75M
10-Q · filed 2015-08-05
2013-12-31$1.30M
10-K · filed 2016-02-26
2012-12-31$1.35M
10-K · filed 2015-02-26
2010-03-31$350.00K
10-Q · filed 2010-05-03
2009-12-31$2.10M
10-K · filed 2010-02-25
2008-12-31$0.00
10-K · filed 2010-02-25
2007-12-31$17.55M
10-K · filed 2010-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sotera Health Co (SHC)United States$5.271B30.96
Progyny, Inc. (PGNY)United States$1.994B28.37
agilon health, inc. (AGL)United States$1.272B-7.76
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43